 SOUTH SAN FRANCISCO, Calif., July 14, 2022 GLOBE NEWSWIRE -- Vaxart, Inc. Nasdaq: VXRT today announced that Dr. Sean Tucker, SVP and Chief Scientific Officer, and Dr. Rebecca Flitter, Senior Scientist, each will present data from the companys COVID-19 oral tablet vaccine development program at the International Congress of Mucosal Immunology 2022, which is being held in Seattle July 16 to 20, 2022. 